Moringa oleifera Lam. Peptide Remodels Intestinal Mucosal Barrier by Inhibiting JAK-STAT Activation and Modulating Gut Microbiota in Colitis

Researchers isolated a specific peptide called MOP (sequence KETTTIVR) from moringa seeds and tested its effects on inflammatory bowel disease using mice with chemically-induced colitis. The peptide demonstrated significant protective effects against intestinal inflammation and damage. When administered to mice with dextran sulfate sodium (DSS)-induced colitis, MOP reduced pathological symptoms, decreased inflammation markers, and helped restore the intestinal barrier that becomes compromised during inflammatory bowel disease. The study used advanced molecular techniques including RNA sequencing to show that MOP works by blocking the JAK-STAT signaling pathway, which is a key driver of inflammation in the intestines. Additionally, the researchers used 16S rRNA gene sequencing to demonstrate that MOP helps restore healthy gut bacteria populations that become disrupted during colitis. Metabolomics analysis revealed that the peptide also normalizes disturbed lipid and amino acid metabolism associated with inflammatory bowel disease. This research is significant because it identifies a specific bioactive compound from moringa seeds and explains the molecular mechanisms behind its anti-inflammatory effects, potentially offering a natural approach for managing inflammatory bowel conditions.